Tiziana Life Sciences

(NASDAQ) TLSA

Current Price$1.39

Market Cap$159.26M

Since IPO (2021)-11%

5 Year-48%

1 Year+4%

1 Month+7%

Tiziana Life Sciences Financials at a Glance

Market Cap

$159.26M

Revenue (TTM)

$0.00

Net Income (TTM)

$31.22M

EPS (TTM)

$-0.16

P/E Ratio

-11.72

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$1.39

Volume

77,630.601

Open

$1.32

Price

$1.39

Volume

77,630.601

Open

$1.32

Previous Close

$1.34

Daily Range

$1.31 - $1.41

52-Week Range

$1.14 - $2.60

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$1.39

Volume

77,630.601

Open

$1.32

Previous Close

$1.34

Daily Range

$1.31 - $1.41

52-Week Range

$1.14 - $2.60

TLSA News

No articles available.

TLSA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tiziana Life Sciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ivor Elrifi, PhD

Website

www.tizianalifesciences.com

Headquarters

London, W1K 1NA, GB

TLSA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-924%

Return on Capital

-45%

Return on Assets

-37%

Earnings Yield

-8.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$159.26M

Shares Outstanding

118.85M

Volume

77.63K

Avg. Volume

148.82K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$15.79M

EBITDA

$16.62M

Operating Cash Flow

$1.22M

Capital Expenditure

$15.18K

Free Cash Flow

$1.23M

Cash & ST Invst.

$3.72M

Total Debt

$106.00K

Tiziana Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$88.00K

-314.6%

Gross Margin

0.00%

N/A

Market Cap

$159.26M

N/A

Market Cap/Employee

$17.70M

N/A

Employees

N/A

Net Income

$5.63M

+34.6%

EBITDA

$5.54M

+35.2%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$7.14M

+14.4%

Accounts Receivable

$4.95M

-42.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$107.00K

-37.1%

Return on Assets

-36.98%

N/A

Return on Invested Capital

-44.82%

N/A

Free Cash Flow

$6.83M

+24.1%

Operating Cash Flow

$6.82M

+24.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.25+3.76%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$4.21+5.64%

EXOZeXoZymes, Inc.

EXOZeXoZymes, Inc.$10.13+3.90%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.20+0.42%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.28+2.52%

ESLAEstrella Immunopharma, Inc.

ESLAEstrella Immunopharma, Inc.$1.61-1.23%

OKYOOKYO Pharma Limited

OKYOOKYO Pharma Limited$1.69+1.51%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.36+2.62%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.74-0.02%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.82+1.03%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$14.53-0.60%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.02-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.87+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$51.22+0.02%

Questions About TLSA

What is the current price of Tiziana Life Sciences?

Tiziana Life Sciences is trading at $1.39 per share.

What is the 52-week range for Tiziana Life Sciences?

Over the past 52 weeks, Tiziana Life Sciences has traded between $1.14 and $2.60.

How much debt does Tiziana Life Sciences have?

As of the most recent reporting period, Tiziana Life Sciences reported total debt of $456,000.

How much cash does Tiziana Life Sciences have on hand?

Tiziana Life Sciences reported $4.01M in cash and cash equivalents in its most recent financial results.

What is Tiziana Life Sciences’s dividend yield?

Tiziana Life Sciences does not currently have a dividend yield.

Tiziana Life Sciences

Tiziana Life Sciences Financials at a Glance

TLSA News

TLSA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tiziana Life Sciences

TLSA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tiziana Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TLSA

What is the current price of Tiziana Life Sciences?

What is the 52-week range for Tiziana Life Sciences?

How much debt does Tiziana Life Sciences have?

How much cash does Tiziana Life Sciences have on hand?

What is Tiziana Life Sciences’s dividend yield?

Premium Investing Services